Bahadır Ermeç1, Uğur Yucetas2, Haydar Güler3, Mehmet Gokhan Culha1, Mustafa Kadıhasanoğlu3. 1. University of Health Sciences, Prof. Dr. Cemil Tascioglu City Hospital, Department of Urology - Istanbul, Turkey. 2. Istanbul Training and Research Hospital, Department of Urology - Istanbul, Turkey. 3. Kanuni Sultan Suleyman Training and Research Hospital, Department of Urology - Istanbul, Turkey.
Abstract
OBJECTIVE: The aim of this study was to evaluate the quality of life of patients with lifelong and acquired premature ejaculation and to examine its relationship with depression and anxiety. METHODS: Between February 2017 and January 2018, a total of 175 patients with premature ejaculation and 132 control men who applied to the urology department of the training and research hospital with the complaint of Premature Ejaculation were included. Patients were divided into three groups according to International Society for Sexual Medicine (ISSM) criteria as follows: Group 1, lifelong premature ejaculation; Group 2, acquired premature ejaculation, and Group 3, control group without premature ejaculation. A detailed medical history of patients was obtained and physical examinations were performed. Intravaginal ejaculation latency time (IELT) was recorded and patients were administered International Erectile Function Index-5 (IIEF-5), Premature Ejaculation Diagnostic Tool (PEDT), Sexual Health Inventory for Men (SHIM), Beck Depression Inventory (BDI), State-Trait Anxiety Inventory (STAI)-1 and STAI-2, and Short Form-36 (SF-36). RESULTS: The mean mental component score (MCS) of the SF-36 was 51.65±6.57 in the lifelong premature ejaculation group, 49.33±8.65 in the acquired premature ejaculation group, and 61.12±11.09 in the control group (p<0.0001). The mean physical component score (PCS) was 50.99±7.43 in the lifelong premature ejaculation group, 48.32±11.58 in the acquired premature ejaculation group, and 55.17±8.10 in the control group (p<0.0001). Quality of life of premature ejaculation patients as assessed by SF-36 was lower in the subscales of physical functioning, general health perception, vitality, and role limitations due to emotional functioning, compared to the control group. CONCLUSIONS: Lifelong and acquired premature ejaculation patients deteriorate their quality of life: the deterioration in these patients' quality of life also negatively affects their depression and anxiety states.
OBJECTIVE: The aim of this study was to evaluate the quality of life of patients with lifelong and acquired premature ejaculation and to examine its relationship with depression and anxiety. METHODS: Between February 2017 and January 2018, a total of 175 patients with premature ejaculation and 132 control men who applied to the urology department of the training and research hospital with the complaint of Premature Ejaculation were included. Patients were divided into three groups according to International Society for Sexual Medicine (ISSM) criteria as follows: Group 1, lifelong premature ejaculation; Group 2, acquired premature ejaculation, and Group 3, control group without premature ejaculation. A detailed medical history of patients was obtained and physical examinations were performed. Intravaginal ejaculation latency time (IELT) was recorded and patients were administered International Erectile Function Index-5 (IIEF-5), Premature Ejaculation Diagnostic Tool (PEDT), Sexual Health Inventory for Men (SHIM), Beck Depression Inventory (BDI), State-Trait Anxiety Inventory (STAI)-1 and STAI-2, and Short Form-36 (SF-36). RESULTS: The mean mental component score (MCS) of the SF-36 was 51.65±6.57 in the lifelong premature ejaculation group, 49.33±8.65 in the acquired premature ejaculation group, and 61.12±11.09 in the control group (p<0.0001). The mean physical component score (PCS) was 50.99±7.43 in the lifelong premature ejaculation group, 48.32±11.58 in the acquired premature ejaculation group, and 55.17±8.10 in the control group (p<0.0001). Quality of life of premature ejaculation patients as assessed by SF-36 was lower in the subscales of physical functioning, general health perception, vitality, and role limitations due to emotional functioning, compared to the control group. CONCLUSIONS: Lifelong and acquired premature ejaculation patients deteriorate their quality of life: the deterioration in these patients' quality of life also negatively affects their depression and anxiety states.
Authors: David Rowland; Michael Perelman; Stanley Althof; James Barada; Andrew McCullough; Scott Bull; Carol Jamieson; Kai-Fai Ho Journal: J Sex Med Date: 2004-09 Impact factor: 3.802
Authors: Tara Symonds; Michael A Perelman; Stanley Althof; François Giuliano; Mona Martin; Kathryn May; Lucy Abraham; Anna Crossland; Mark Morris Journal: Eur Urol Date: 2007-01-16 Impact factor: 20.096
Authors: Ege C Serefoglu; Onder Yaman; Selahittin Cayan; Ramazan Asci; Irfan Orhan; Mustafa F Usta; Oguz Ekmekcioglu; Muammer Kendirci; Bulent Semerci; Ates Kadioglu Journal: J Sex Med Date: 2010-11-03 Impact factor: 3.802
Authors: Mehmet Gokhan Culha; Murat Tuken; Serkan Gonultas; Omer Onur Cakir; Ege Can Serefoglu Journal: Int J Impot Res Date: 2019-09-03 Impact factor: 2.896
Authors: Ege Can Serefoglu; Chris G McMahon; Marcel D Waldinger; Stanley E Althof; Alan Shindel; Ganesh Adaikan; Edgardo F Becher; John Dean; Francois Giuliano; Wayne Jg Hellstrom; Annamaria Giraldi; Sidney Glina; Luca Incrocci; Emmanuele Jannini; Marita McCabe; Sharon Parish; David Rowland; R Taylor Segraves; Ira Sharlip; Luiz Otavio Torres Journal: Sex Med Date: 2014-06 Impact factor: 2.491